Yttrium hydrochloride is a chemical compound containing yttrium, a rare earth element from the lanthanide group. It is primarily used in industrial and medical applications, such as the production of phosphorescent materials, lasers, and in cancer treatments. In medicine, yttrium isotopes, such as yttrium-90, are used in radioembolization therapies for treating liver cancer and other tumors.
Yttrium hydrochloride is used as a precursor in the synthesis of other yttrium compounds and in advanced materials research. In medical applications, the compound is handled with care to minimize radiation exposure and ensure the safety of patients and medical personnel.
Side effects associated with yttrium use in medicine depend on the specific form and application. In the case of radioembolization, adverse reactions may include fatigue, nausea, abdominal pain, and, in rare cases, liver function impairment.
Handling yttrium hydrochloride requires strict adherence to safety protocols, especially in medical applications involving radiation. This compound plays a significant role in various fields, from technology to medicine, contributing to the development of innovative solutions for treating severe diseases.